Ordesekimab manufacturers
- Ordesekimab
-
- $97.00
-
2026-07-27
- CAS:879293-15-9
- Purity: > 95%
- Supply Ability: 10g
|
| | Ordesekimab Basic information |
| | Ordesekimab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Ordesekimab Usage And Synthesis |
| Uses | Ordesekimab (AMG 714; PRV-015) is a fully human IgG1κ anti-IL-15 (Interleukin Related) monoclonal antibody. The binding of Ordesekimab to IL-15 inhibits the interaction of IL-15 with the IL-2Rβ and common γ chain of the IL-15 receptor complex, but not with the IL-15Rα chain. Ordesekimab has the potential for study of nonresponsive celiac disease (NRCD)[1]. | | IC 50 | IL-15 | | References | [1] Yu-Ling Wei, et al. Strategies to evaluate potential effector function of glycan variants: a case study of ordesekimab (AMG 714 or PRV-015). J Immunotoxicol. 2022 Dec;19(1):109-116. DOI:10.1080/1547691X.2022.2113841 |
| | Ordesekimab Preparation Products And Raw materials |
|